Jiwei Huang

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

Cancer communications (London, England)

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ruopeng Su, Tingxuan Huang, Liangyou Gu, Yige Bao, Zhihong Liu, Pinghong Dao, Lin Yao, Xiaoyi Hu, Guanghou Fu, Jitao Wu, Thibault Tricard, Guangyu Wu, Minfeng Chen, Chancan Li, Zhiyang Huang, Bing Zheng, Yonghui Chen, Wei Xue, Gang Guo, Pei Dong, Jiwei Huang, Jin Zhang
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study. Cancer medicine 13 (17) (2024)
Jiwei Huang, Yueming Wang, Fan Xu, Zaoyu Wang, Guangyu Wu, Wen Kong, N G Cheoklong, Thibault Tricard, Xiaorong Wu, Wei Zhai, Wei Zhang, Jiyang Zhang, Ding Zhang, Shuyin Chen, Yuqing Lian, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. Journal for immunotherapy of cancer 12 (6) (2024)
Jiwei Huang, Yueming Wang, Fan Xu, Zaoyu Wang, Guangyu Wu, Wen Kong, N G Cheoklong, Thibault Tricard, Xiaorong Wu, Wei Zhai, Wei Zhang, Jiyang Zhang, Ding Zhang, Shuyin Chen, Yuqing Lian, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. Journal for immunotherapy of cancer 12 (6) (2024)
Jiwei Huang, Yueming Wang, Fan Xu, Zaoyu Wang, Guangyu Wu, Wen Kong, N G Cheoklong, Thibault Tricard, Xiaorong Wu, Wei Zhai, Wei Zhang, Jiyang Zhang, Ding Zhang, Shuyin Chen, Yuqing Lian, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. Journal for immunotherapy of cancer 12 (6) (2024)
Jiwei Huang, Yueming Wang, Fan Xu, Zaoyu Wang, Guangyu Wu, Wen Kong, N G Cheoklong, Thibault Tricard, Xiaorong Wu, Wei Zhai, Wei Zhang, Jiyang Zhang, Ding Zhang, Shuyin Chen, Yuqing Lian, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. Journal for immunotherapy of cancer 12 (6) (2024)
Ruopeng Su, Liangren Liu, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hai-Long Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study. Cancer medicine (2023)
Yueming Wang, Jiwei Huang, Cuijian Zhang, Xiaoyi Hu, Ping Wang, Guohai Shi, Jin Zhang, Wen Kong, Yonghui Chen, Yiran Huang, Dingwei Ye, Dan Xia, Jianming Guo, Zhisong He, Wei Xue
Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy. International journal of cancer 152 (1) (2022)
Jiwei Huang, Yueming Wang, Haoran Zhang, Xiaoyi Hu, Ping Wang, Wen Cai, Yichu Yuan, Hao Zeng, Jin Zhang, Wen Kong, Yiran Huang, Shuo Wang, Jianming Guo, Qiang Wei, Wei Xue
Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody. Cancer communications (London, England) 41 (10) (2021)

Jiwei Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jiwei Huang